Literature DB >> 26122791

Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.

Stephen M Stahl.   

Abstract

Vortioxetine is an antidepressant with multiple pharmacologic modes of action at targets where serotonin neurons connect with other neurons. 5HT3 receptor antagonism is one of these actions, and this leads to increased release of norepinephrine (NE), acetylcholine (ACh), and serotonin (5HT) within various brain circuits.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122791     DOI: 10.1017/S1092852915000346

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  5 in total

1.  [Role of cAMP/CREB/BDNF signaling pathway in anti-depressive effect of vortioxetine in mice].

Authors:  Hui Yu; Jia-Jia Chen; Bing-Qing Zeng; Qiu-Ping Zhong; Jiang-Ping Xu; Yong-Gang Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

Review 2.  Vortioxetine for depression in adults.

Authors:  Markus Koesters; Giovanni Ostuzzi; Giuseppe Guaiana; Johanna Breilmann; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2017-07-05

Review 3.  Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Authors:  Giuseppe Di Giovanni; Dubravka Svob Strac; Montse Sole; Mercedes Unzeta; Keith F Tipton; Dorotea Mück-Šeler; Irene Bolea; Laura Della Corte; Matea Nikolac Perkovic; Nela Pivac; Ilse J Smolders; Anna Stasiak; Wieslawa A Fogel; Philippe De Deurwaerdère
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

Review 4.  Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.

Authors:  Grace Chen; Astrid-Maria Højer; Johan Areberg; George Nomikos
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

5.  When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipity.

Authors:  Penelope Lowe; Amir Krivoy; Lilla Porffy; Erna Henriksdottir; Whiskey Eromona; Sukhwinder S Shergill
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.